INNOVATE BIOPHARMACEUTICLS I's ticker is and the CUSIP is 45782F955. A total of 1 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $8,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | +700.0% | 15,000 | +4900.0% | 0.00% | – |
Q1 2019 | $1,000 | -92.9% | 300 | -95.2% | 0.00% | – |
Q4 2018 | $14,000 | -91.8% | 6,200 | -75.3% | 0.00% | -100.0% |
Q3 2018 | $171,000 | -37.4% | 25,100 | +116.4% | 0.00% | -50.0% |
Q2 2018 | $273,000 | – | 11,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |